I am a neuro-oncologist specializing in care for patients with primary brain tumors — including gliomas, glioblastomas, meningiomas, ependymomas, and primary central nervous system lymphomas — as well as the neurologic complications of cancer. I am one of the leaders of the inpatient multidisciplinary team of professionals providing the highest quality treatment for patients and the best possible care for their families.
Read more
I am involved in ongoing clinical trials for patients with primary brain tumors.
I am fluent in English, Russian, and Ukrainian.
What I Do at MSK
A neurologist is a doctor with special training in the brain, spinal cord, nerves, and muscles.
A neuro-oncologist is a doctor with special training in cancers that affect the brain, spinal cord, peripheral nerves, and muscles. This includes brain tumors and central nervous system tumors.
Director, Neuro-Oncology Fellowship Program
Areas of Expertise
Conditions I Treat
Brain tumors
Gliomas
Central nervous system (CNS) lymphoma
Leptomeningeal disease
My Specialties
Neuro-oncology
Education & Honors
Education
MD, Kharkov Medical University
Residencies
Internal Medicine/Neurology - Hospital of Emergency Care
Fellowships
Neuro-Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Neurology
Neuro-oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
4.8150 reviews
4.8Provider's Explanations Easy to Understand
4.8Trusts Provider with Care
4.9Provider Listened Carefully
4.8Likelihood of Recommending Provider
Mar 4, 2025
Great overall
Feb 27, 2025
Dr. Pentsova was very thorough, very professional and very caring. She explained clearly all my problems and present to me alternatives of care. My family and I really like her very much.
Feb 25, 2025
Dr Pentsova saved my life. I feel extremely grateful and lucky to have her as my doctor. She is the very, very best!
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Elena Pentsova discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.